home / stock / soly / soly news

SOLY News and Press, Soliton Inc. From 03/20/20

Stock Information
Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com
Menu
SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...
SOLY - Lead Investigator Evaluates Next-Step for Soliton Pivotal Cellulite Clinical Data

HOUSTON , March 20, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...
SOLY - Soliton Receives FDA Clearance of Special 510(k)

HOUSTON , March 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...

SOLY - Soliton signs Agreement with Global Manufacturer Sanmina

HOUSTON , March 9, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020

Today, we will see why Soliton ( SOLY ) is a promising pick for 2020. Company overview Soliton, Inc. is a pre-revenue stage medical device company focused on the development and commercialization of innovative products for removing unwanted tattoos. The company's proprietary RAP (Rapid...
SOLY - Global Medical Device Industry Bolstering Outstanding Growth Potentials

February 11, 2020 Palm Beach, FL – February 11, 202- There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future… and most likely beyond then. It also should see ...

SOLY - Soliton Files Special 510(k) with FDA for its Generation II RAP Device

HOUSTON , Feb. 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales Consultant

HOUSTON , Feb. 6, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today an...
SOLY - Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials

HOUSTON , Jan. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Pulse Biosciences: Bioscience That Doesn't Get Our Pulse Racing

Editor's note: Seeking Alpha is proud to welcome Marvl Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » CellFX, a Pulse Bi...

SOLY - Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

HOUSTON , Jan. 13, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
Previous 10 Next 10